Diverse associations observed between pregnancy complications and RBC or plasma folates determined by an in-house developed LC-MS/MS method

Ann Med. 2023;55(2):2265381. doi: 10.1080/07853890.2023.2265381. Epub 2023 Oct 12.

Abstract

Background: As folates are essential for embryonic development and growth, it is necessary to accurately determine the levels of folates in plasma and red blood cells (RBCs) for clinical intervention. The aims of this study were to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantitation of folates in plasma and RBCs and to examine the association between plasma and RBC folate concentrations and gestational diabetes mellitus (GDM), gestational hypertension (GH) and preeclampsia (PE).

Methods: With the in-house developed LC-MS/MS, a retrospective cross-sectional study was conducted. The healthy pregnant women of first- (n = 147), second- (n = 84) and third-trimester (n = 141) or the women diagnosed with GDM (n = 84), GH (n = 58) or PE (n = 23), that were aged between 22 and 46 years old and registered at our institute, were subjected for measurement of folic acid (FA) and 5-methyltetrahydrofolate (5-MTHF), followed by appropriate statistical association analysis.

Results: The assay for simultaneous quantitation of FA and 5-MTHF in plasma and RBCs was linear, stable, with imprecision less than 15% and recoveries within ±10%. The lower limits of quantification for FA and 5-MTHF measurement in whole blood were 0.57 and 1.09 nmol/L, and in plasma were 0.5 and 1 nmol/L, respectively. In the association analysis, the patients with lower RBC folate level (<906 nmol/L) presented higher risks of PE development (OR 4.861 [95% CI 1.411-16.505]) by logistic regression and restricted cubic spline (RCS) regression in a nonlinear fashion. In addition, higher level of plasma folates in pregnancy was significantly associated with GH risk but may be protective for the development of GDM.

Conclusions: The in-house developed LC-MS/MS method for folates and metabolites in plasma or RBC showed satisfactory analytical performance for clinical application. Further, the levels of folates and metabolites were diversely associated with GDM, GH and PE development.

Keywords: Folate; LC-MS/MS; RBC; gestational diabetes mellitus; gestational hypertension; plasma; preeclampsia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Chromatography, Liquid
  • Cross-Sectional Studies
  • Erythrocytes / chemistry
  • Female
  • Folic Acid / analysis
  • Humans
  • Middle Aged
  • Pre-Eclampsia*
  • Pregnancy
  • Retrospective Studies
  • Tandem Mass Spectrometry* / methods
  • Young Adult

Substances

  • Folic Acid

Grants and funding

This work was supported by the Training Fund for Open Projects at Clinical Institutes and Departments of Capital Medical University (CCMU2022ZKYXZ006), the Beijing Municipal Administration of Hospitals Incubating Program (No. PX2022058) and High-level Construction Project of Public Health Technical Personnel in Beijing Municipal Health System (No. Lingjunrencai-02-02). The funding bodies did not take part in the design of the study, the collection, analysis and interpretation of the data, or manuscript writing.